The 63 rating InvestorsObserver gives to Relmada Therapeutics Inc (RLMD) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 85 percent of stocks in the Biotechnology industry, RLMD’s 63 overall rating means the stock scores better than 63 percent of all stocks.
RLMD has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on RLMD!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 63 means the stock is more attractive than 63 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Relmada Therapeutics Inc Stock Today?
Relmada Therapeutics Inc (RLMD) stock is trading at $2.96 as of 9:54 AM on Wednesday, Sep 20, an increase of $0.17, or 6% from the previous closing price of $2.79. Volume today is high. So far 1,702,658 shares have traded compared to average volume of 96,958 shares. The stock has traded between $2.85 and $3.50 so far today.
Click Here to get the full Stock Report for Relmada Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter